Insulet Operating Cycle from 2010 to 2026
| PODD Stock | USD 250.85 1.56 0.62% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 362.7 | Current Value 268.55 | Quarterly Volatility 271.06213735 |
Check Insulet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insulet's main balance sheet or income statement drivers, such as Interest Expense of 51.6 M, Other Operating Expenses of 2.1 B or Operating Income of 373 M, as well as many indicators such as Price To Sales Ratio of 15.94, Dividend Yield of 0.0 or PTB Ratio of 19.9. Insulet financial statements analysis is a perfect complement when working with Insulet Valuation or Volatility modules.
Insulet | Operating Cycle | Build AI portfolio with Insulet Stock |
Analyzing Insulet's Operating Cycle over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Cycle has evolved provides context for assessing Insulet's current valuation and future prospects.
Latest Insulet's Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Insulet over the last few years. It is Insulet's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Insulet's overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Insulet Operating Cycle Regression Statistics
| Arithmetic Mean | 262.66 | |
| Geometric Mean | 194.58 | |
| Coefficient Of Variation | 103.20 | |
| Mean Deviation | 161.24 | |
| Median | 184.24 | |
| Standard Deviation | 271.06 | |
| Sample Variance | 73,475 | |
| Range | 1.2K | |
| R-Value | (0.05) | |
| Mean Square Error | 78,136 | |
| R-Squared | 0 | |
| Significance | 0.83 | |
| Slope | (2.95) | |
| Total Sum of Squares | 1.2M |
Insulet Operating Cycle History
About Insulet Financial Statements
Insulet stakeholders use historical fundamental indicators, such as Insulet's Operating Cycle, to determine how well the company is positioned to perform in the future. Although Insulet investors may analyze each financial statement separately, they are all interrelated. For example, changes in Insulet's assets and liabilities are reflected in the revenues and expenses on Insulet's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Insulet. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 362.70 | 268.55 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports:Check out the analysis of Insulet Correlation against competitors. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Will Health Care Equipment & Supplies sector continue expanding? Could Insulet diversify its offerings? Factors like these will boost the valuation of Insulet. Anticipated expansion of Insulet directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Insulet data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.148 | Earnings Share 3.41 | Revenue Per Share | Quarterly Revenue Growth 0.299 | Return On Assets |
Understanding Insulet requires distinguishing between market price and book value, where the latter reflects Insulet's accounting equity. The concept of intrinsic value - what Insulet's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Insulet's price substantially above or below its fundamental value.
It's important to distinguish between Insulet's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Insulet should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Insulet's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.